CYTOPATHFINDER INC has a total of 31 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are UNIV OF VIRGINIA PATENT FOUNDA, AGY THERAPEUTICS INC and STELIC INSTITUTE REGENERATIVE MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Australia | 6 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | United States | 4 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Computer technology | |
#5 | Measurement | |
#6 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Bioinformatics | |
#4 | Heterocyclic compounds | |
#5 | Microorganisms | |
#6 | Medical preparations | |
#7 | Measuring microorganism processes | |
#8 | Microbiology | |
#9 | Sugars | |
#10 | Materials for miscellaneous applications |
# | Name | Total Patents |
---|---|---|
#1 | Fujita Yoshiji | 15 |
#2 | Yoshikawa Tomohiro | 13 |
#3 | Miyake Masato | 10 |
#4 | Koerner Steffi | 6 |
#5 | Lin Jian | 6 |
#6 | Chen Dongli | 6 |
#7 | Fichman Merav | 6 |
#8 | Ghosh Shomir | 6 |
#9 | Zhang Zhaoda | 6 |
#10 | Marantz Yael | 6 |
Publication | Filing date | Title |
---|---|---|
WO2010129843A1 | Dihydronaphthyridinyl and related compounds for use in treating ophthalmological disorders | |
AU2008335135A1 | Carboxamide compounds and their use as chemokine receptor agonists | |
US2010331298A1 | Carboxamide Compounds and Their Use | |
US2011165664A1 | Transfection device utilizing sericin | |
EP2145183A2 | Compound profiling method | |
WO2007043523A1 | Transfection device | |
JP2007236224A | Transfection device |